The Trade Alliance to Promote Prosperity has responded to a Centers for Medicare & Medicaid Services request for comments on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program…
Read MoreThe Trade Alliance to Promote Prosperity today provided comments to the U.S. Senate Committee on Health, Education, Labor, & Pensions at the request of Chairman Bill Cassidy on the 340B Drug Pricing Integrity and Affordability for Patients Act…
Read MoreThe Trade Alliance to Promote Prosperity today responded to a U.S. Senate Finance Committee Request for Information (RFI) seeking input on commonsense policy options to lower drug prices for patients…
Read MoreThe Trade Alliance to Promote Prosperity has responded to a U.S. Trade Representative Request for Public Comments on Germany's Persistent Underpayment for Innovative Pharmaceutical Products, pursuant to the agency’s initiation of a Section 301 investigation…
Read MoreOn July 14, the Senate Judiciary Committee is expected to hold a hearing on the Patent Eligibility Restoration Act (PERA)—bipartisan legislation that represents one of the most significant opportunities in years to strengthen America’s innovation economy. The Trade Alliance to Promote Prosperity strongly support PERA because it would restore clarity, certainty, and confidence to the U.S. patent system…
Read MoreThe Trade Alliance to Promote Prosperity welcomes congressional consideration of the Tax-Exempt Hospital Transparency Act, a commonsense measure that would bring long-overdue transparency and accountability to the nation's tax-exempt hospital sector, and urges its swift passage…
Read MoreThe Trade Alliance to Promote Prosperity (TAPP) applauds the American Edge Project for its new advertising campaign highlighting one of the most important stories of our time: how artificial intelligence is transforming healthcare and improving lives…
Read MoreToday, the Trade Alliance to Promote Prosperity wrote to the U.S. Senate Committee on Health, Education, Labor, & Pensions (HELP) to urge members to reject three bills that would undermine U.S. medical innovation: S. 2658, The Medication Affordability and Patent Integrity Act; S. 1954, The Biosimilar Red Tape Elimination Act; S. 3014, Ensuring Timely Access to Generics Act of 2025…
Read MoreThe Trade Alliance to Promote Prosperity has signed onto a letter to Congress, urging opposition to efforts to quash direct-to-consumer advertising of prescription drugs…
Read MoreWhat began as a well-intentioned effort to help vulnerable patients afford medicines has morphed into one of the fastest growing and least transparent programs in American healthcare, and the Trade Alliance to Promote Prosperity has created a new cartoon to illustrate the problem…
Read MoreThe federal 340B drug pricing program was created with a simple and admirable goal: help vulnerable and low-income patients access discounted medications. But that’s not how the program has played out. The Trade Alliance to Promote Prosperity has produced a cartoon to illustrate this sad truth…
Read MoreThe House Judiciary IP Subcommittee recently announced a hearing to be held on June 4 on the ways that patents and other intellectual property rights relate to drug prices. The Trade Alliance to Promote Prosperity sent a letter to subcommittee members, urging IP rights protection…
Read MoreAs America approaches its 250th birthday, we are reflecting not only on our history, but on the ideas and institutions that made the United States the most innovative and economically dynamic nation in the world. For two and a half centuries, America’s strength has rested on a simple principle: When people are free to create, compete, and trade, prosperity follows. That principle matters just as much today, and we have created an editorial cartoon to celebrate…
Read MoreFor years, Americans have been told that high prescription drug prices are simply the unavoidable cost of innovation. But a growing body of evidence suggests something else is driving costs higher: a deeply opaque system dominated by pharmacy benefit managers (PBMs), insurance companies, and pharmacy chains that increasingly operate under the same corporate umbrella. The Trade Alliance to Promote Prosperity has created a new cartoon to illustrate the burden that the vertically integrated system has placed on patients, employers, unions, and taxpayers…
Read MoreThe Trade Alliance to Promote Prosperity has created a new editorial cartoon to illustrate a big “oops” by Congress: The 340B drug pricing program. Congress created the 340B program in 1992 with a genuinely noble purpose: help hospitals and clinics serving low-income Americans stretch limited resources and provide more care to vulnerable patients…
Read MoreThe Trade Alliance to Promote Prosperity joined a coalition of 40 organizations on sending a letter to the U.S. House of Representatives today, urging support the Abolish the Center for Medicare and Medicaid Innovation (CMMI) Act…
Read MoreThe 340B drug pricing program was created with a simple and worthy goal: help hospitals and clinics serving low-income and uninsured patients purchase prescription drugs at steep discounts so they could stretch limited resources and provide more care. The Trade Alliance to Promote Prosperity has created an editorial cartoon to illustrate the issue…
Read MoreAhead of an expected U.S. Senate “vote-a-rama” on May 21, the Trade Alliance to Promote Prosperity today wrote to member of Congress, urging them to reject proposals and amendments to impose “most favored nation” drug pricing policies…
Read MoreThe Trade Alliance to Promote Prosperity has signed onto a coalition letter, along with 35 other organizations, urging Congress to Repeal the Jones Act…
Read MoreThe Trade Alliance to Promote Prosperity penned an op-ed for the Kentucky State Journal, saying that, as chair of the House Energy & Commerce Committee, U.S. Representative Brett Guthrie should stand against the Trump administration's "most favored nation" drug-pricing plan…
Read More